Akkermansia muciniphila ATCC BAA-835

Akkermansia muciniphila ATCC BAA-835 is a mesophilic, chemoheterotrophic, Gram-negative bacterium that exhibits a rod-shaped morphology and is primarily found in the intestinal mucosa of various mammals, including humans. This microbe thrives in the oxygen-reduced environments of the gut, classified as an obligate anaerobe, which allows it to effectively colonize the mucosal layer and interact with the host's immune system. As a chemoheterotroph, A. muciniphila derives its energy from organic compounds, primarily utilizing mucin as its main carbon source. Mucin, a glycoprotein component of mucus, serves as both a nutrient and a structural component in the gut environment, which A. muciniphila actively degrades. This metabolic capability not only facilitates its growth but also contributes to the maintenance of gut health by supporting the integrity of the mucosal barrier and promoting the growth of other beneficial microbes. The Gram-negative cell wall structure of A. muciniphila is characterized by a thin peptidoglycan layer surrounded by an outer membrane, which plays a crucial role in its resistance to certain antibiotics and influences its interactions with the host's immune system. Its rod shape allows for increased surface area, facilitating nutrient absorption and interactions with the gut lining. Akkermansia muciniphila has garnered attention for its potential health benefits, including its role in obesity management, metabolic syndrome, and overall gut health. Research indicates that higher levels of this microbe are associated with improved metabolic profiles and reduced inflammation. Its ability to modulate the gut microbiome and enhance the mucosal barrier makes it a promising candidate for probiotic applications and therapeutic interventions aimed at improving gut health and preventing various diseases.